Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors

Human Pathology

Volumn 40, Issue 11, 2009, Pages 1643-1649

  Kamo, Nobuyuki ^a   Naomoto, Yoshio ^a   Shirakawa, Yasuhiro ^a   Yamatsuji, Tomoki ^a   Hirota, Seiichi ^b   Fujiwara, Yasuhiro ^a   Noma, Kazuhiro ^a   Sakurama, Kazufumi ^a   Takaoka, Munenori ^a   Nagatsuka, Hitoshi ^a   Gunduz, Mehmet ^a   Matsuoka, Junji ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

FAK; GIST; Immunohistochemistry; Patients' outcome

Indexed keywords

FOCAL ADHESION KINASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, CD34; BLOTTING, WESTERN; DISEASE PROGRESSION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHORYLATION; PROGNOSIS; STEM CELL FACTOR; UP-REGULATION;

EID: 70349882107     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.05.004     Document Type: Article

References (32)

1. Sarlomo-Rikala M., El-Rifai W., Lahtinen T., Andersson L.C., Miettinen M., and Knuutila S. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol 29 (1998) 476-481
2. El-Rifai W., Sarlomo-Rikala M., Andersson L.C., Knuutila S., and Miettinen M. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 60 (2000) 3899-3903
3. Sleijfer S., Wiemer E., and Verweij J. Drug Insight: gastrointestinal stromal tumors (GIST)-the solid tumor model for cancer-specific treatment. Nat Clin Pract Oncol 5 (2008) 102-111
4. Miettinen M., and Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438 (2001) 1-12
5. Miettinen M., El-Rifai W., Sobin L.H., and Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 33 (2002) 478-483
6. Rubin B.P., Singer S., Tsao C., et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61 (2001) 8118-8121
7. Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
8. Verweij J., van Oosterom A., Blay J.Y., et al. Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer 39 (2003) 2006-2011
9. Heinrich M.C., Corless C.L., Demetri G.D., et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21 (2003) 4342-4349
10. Kornberg L.J. Focal adhesion kinase expression in oral cancers. Head Neck 20 (1998) 634-639
11. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nature Rev Mol Cell Biol 6 (2005) 56-68
12. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., and Frame M.C. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5 (2005) 505-515
13. Sieg D.J., Hauck C.R., Ilic D., et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2 (2000) 249-257
14. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., and Weed S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19 (2000) 5606-5613
15. Schwartz M.A., and Ginsberg M.H. Networks and crosstalk: integrin signaling spreads. Nat Cell Biol 4 (2002) E65-E68
16. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., and Parsons J.T. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89 (1992) 5192-5196
17. Hanks S.K., Calalb M.B., Harper M.C., and Patel S.K. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89 (1992) 8487-8491
18. Schaller M.D. The focal adhesion kinase. J Endocrinol 150 (1996) 1-7
19. Parsons J.T. Focal adhesion kinase: the first ten years. J Cell Sci 116 (2003) 1409-1416
20. Cance W.G., Harris J.E., Iacocca M.V., et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 6 (2000) 2417-2423
21. Kim S.J., Park J.W., Yoon J.S., et al. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical Study. J Korean Med Sci 19 (2004) 710-715
22. Sood A.K., Coffin J.E., Schneider G.B., et al. Biological significance of focal adhesion kinase in ovarian cancer. Am J Pathol 165 (2004) 1087-1095
23. Lark A.L., Livasy C.A., Calvo B., et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res 9 (2003) 215-222
24. Theocharis S.E., Kouraklis G.P., Kakisis J.D., et al. Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. Eur J Surg Oncol 29 (2003) 571-574
25. Itoh S., Maeda T., Shimada M., et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10 (2004) 2812-2817
26. Furuyama K., Doi R., Mori T., et al. Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg 30 (2006) 219-226
27. Carelli S., Zadra G., Vaira V., et al. Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer 53 (2006) 263-271
28. Koon N., Schneider S.R., Sarlomo R.M., et al. Molecular targets for tumor progression in gastrointestinal stromal tumors. Gut 53 (2004) 235-240
29. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23 (2006) 70-83
30. Watanabe N., Takaoka M., Sakurama K., et al. Dual-tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Clin Cancer Res 14 (2008) 4631-4639
31. Hasegawa T., Matsuno Y., Shimoda T., and Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33 (2002) 669-676
32. Sakurama K., Noma K., Takaoka M., et al. Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. Mol Cancer Ther 8 (2009) 127-134